World-class scientists, doctors, research specialists and bioinformatics experts lead ITMI's pioneering research. Our team conducts pioneering genomic research studies and translates findings to help Inova doctors improve patient care – and ultimately make medical discoveries that will change the way we personalize and deliver healthcare.
Meet the ITMI team
John Niederhuber, MD
Chief Executive Officer
Dr. Niederhuber brings a lifetime of medical knowledge, large organization management experience and vision to his position as CEO, including his most recent tenure as director of the National Cancer Institute. A nationally renowned surgeon and researcher, he has dedicated his four-decade career to the treatment and study of cancer.
Dr. Niederhuber previously served as NCI's chief operating officer and deputy director for translational and clinical sciences and chair of the National Cancer Advisory Board. He remains involved in research at the National Institutes of Health.
As a surgeon, Dr. Niederhuber's clinical emphasis is on gastrointestinal cancer, hepatobiliary (liver, bile duct, and gallbladder) and breast cancers. He is recognized for his pioneering work in hepatic artery infusion chemotherapy and was the first to demonstrate the feasibility of totally implantable vascular access devices.
Dr. Niederhuber is a member of the Institute of Medicine of the National Academy of Science and has received numerous honors and awards.
Joe Vockley, PhD
Chief Operating Officer and Chief Scientific Officer
Dr. Vockley brings 25 years of experience in academic, pharmaceutical, biotechnology CROs and government research to his roles as COO and CSO. He has vast expertise is in the fields of genetics, genomics, molecular diagnostics, bioinformatics and large program management.
Dr. Vockley is an operations-oriented manager and scientist. He is inventor on numerous US and international genomic and bioinformatic patents in the areas of DNA diagnostics, laboratory methods for microarray analysis, gene discoveries and bioinformatic tool development. His basic research interests are in the fields of cancer and inborn errors of metabolism.
Previously, Dr. Vockley was director of the National Cancer Institute's Cancer Genome Atlas project. He has held the positions of chief scientific officer, vice president of research, director of genomics and director of bioinformatics.
Benjamin D. Solomon, MD
Chief, Division of Medical Genomics
Dr. Solomon, an accomplished scientist and medical geneticist, is dual board-certified in pediatrics and clinical genetics through the National Human Genome Research Institute.
At ITMI, Dr. Solomon leads the Medical Genomics division – a group of clinicians and researchers that focuses on providing genetic and genomic medical care, discovering new explanations for genetic disorders, and studying the best ways to integrate cutting-edge genomic resources into clinical practice.
Previously Dr. Solomon held positions at NIH researching the genetic and genomic causes of both rare and common conditions, especially certain types of congenital anomalies. The author of over 70 peer-reviewed articles and book chapters, Dr. Solomon serves as an editor on a number of medical journals, has edited several medical textbooks, and is actively involved in genetic/genomic training and education.
Ramaswamy Iyer, PhD, FACMG
Director, Clinical Molecular Genetics and Biobanking
Dr. Iyer has spent more than 25 years in the basic and applied research, and clinical laboratory settings. He has directed the operations of CAP/CLIA-certified clinical diagnostic laboratories for more than ten years, supporting both high-quality patient care and clinical research.
At ITMI, Dr. Iyer is responsible for the Institute's laboratory and biobank, He plays a significant role in developing the research and service infrastructure to support research and clinical activities at ITMI and throughout the Inova.
Dr. Iyer previously served at the National Cancer Institute's Cancer Genome Atlas and established a state-of-the-art esoteric genetic testing laboratory and an institute-wide biobank at the University of Michigan. He was trained in clinical molecular genetics and clinical cytogenetics at UCLA-Cedar Sinai in Los Angeles. He is board certified by the American Board of Medical Genetics and is a fellow of the American College of Medical Genetics and Genomics.
Kathi Huddleston, PhD
Director, Clinical Research Projects
Dr. Huddleston brings 20 years' experience with pediatric research. She brings experience in regulations, recruiting, development of research documentation, as well as clinical analysis and team building with bioinformatics, genetics, clinical and EMR data acquisition.
At ITMI, Dr. Huddleston leads the clinical research staff and heads up all patient enrollment and consenting for ITMI studies. She has been instrumental in expanding the Institute's maternal and child health research repertoire and has directed the acquisition of over 10,000 biological samples.
Dr. Huddleston has a doctorate in nursing and health policy from George Mason University. She has been recognized as an Inova Visionary Leader, is a review editor for both the Journal of Emergency Nursing and the American Journal of Maternal Child Nursing, and has published several articles on nutritional support for infants.
Mr. Black has more than 15 years of IT and business experience consolidating and managing large and complex data sets from disparate sources. He holds many certifications in both technical and project management.
At ITMI, Mr. Black and his team are building a world-class bioinformatics infrastructure for the Institute's massive and varied data to support genomics research and clinical services – and ultimately for the purpose of translating genomics research for medical discoveries and improved patient care.
Previously, Mr. Black was the informatics manager and leader for the Biospecimen Core Resource at Nationwide Children’s Hospital and the National Cancer Institute's Cancer Genome Atlas project. He was co-architect for the flexible data model to store and access data from studies for 30+ cancer subtypes and clinical data from biobanks and academic institutions across five continents.
For more information about our team, call us at 703-776-8199.